© 2014 OKB Medical Limited. All rights reserved.
OKB Medical Limited
Unique and Innovative Healthcare Products
STAN® S41 FECG ST-Analysis System
ST-Analysis of the Fetal ECG during Intrapartum CTG Monitoring
STAN® ST - STAN® Fetal ECG ST-Analysis
STAN® S41
4 in 1
4 Systems
in 1 Unit
1. CTG
High Quality Intrapartum
Fetal Monitor with many
unique functions:
- Large Touchscreen
- On-Screen Review of the entire CTG recording with all events and notes
- Touchscreen Keyboard function with free text notes and quick annotations
- Unambiguous Colour Coded monitoring of Twin Heart Rates
- Unambiguous Colour and signal Coding for continuous Maternal Heart Rate Monitoring
2. ST-Analysis
Fetal ECG ST-Analysis, which is
unique to STAN®, is an additional parameter that is recorded by STAN® together with the CTG. FECG ST-Analysis has proven to:
- Improve Fetal Outcome
- Reduce Unnecessary Interventions
- Fetal Blood Sampling is eliminated
- Increase Inter-Observer Agreement
3. Archiving
STAN® automatically and digitally stores the entire CTG recording with all notes and provides:
- Internal Digital Storage
- Direct Network Archiving onto Hospital Server
- Electronic Auditing of the CTG and notes
- Review, Copy & e-Mail CTGs
- Paperless Monitoring with no loss or fading of CTG Recordings
4. Integral Telemetry
Built-In Telemetry Unit with Waterproof Wireless Transducers
STAN®
Evidence Based Medicine
The use of Fetal ECG ST-Analysis is supported by the Cochrane Reviewers and approved by the FDA to reduce the risk of Brain Injury during labour. STAN® also enables you to comply with the CNST Recommendations for secure long-term archiving of the CTG.
STAN®
Is the only Fetal Monitor proven to reduce the risk of brain injury during labour.
OPTIONS
With STAN® ST:
- Network Archiving
- STAN® Viewer
- STAN® Viewer Live
- Wireless Transducers
- Maternal Parameters
- Short Term Variation
Consumables
With STAN® ST:
- GoldTrace
- Skin Electrodes
Educational Material:
- STAN® Textbook
- CTG Pocket Guide
- CTG Ruler
- STAN® Guidelines
- e-Learning
- Training Courses
The all-new STAN® S41
Great today, brilliant for
the future
S
T
A
N
F
E
C
G
S
T
-
A
N
A
L
Y
S
I
S
For further information on STAN
FECG ST-Analysis,
STAN® S41 Fetal ECG ST-Analysis:
STAN® S41 is a unique, one-of-a-kind, fetal monitor which combines standard CTG technology with fetal ECG ST-Analysis. The fetal ECG ST-Analysis adds a new dimension to fetal monitoring, which provides the obstetric and midwifery staff with a deeper insight into the fetal physiological reaction to events and the capability of the foetus to cope during the stress of labour and, hence, enabling the obstetric and midwifery staff to make a more informed decision on the best action to take at the time.
STAN® FECG ST-Analysis has Proven Clinical Benefits
STAN® has been developed through a long and thorough process of research and validation, and the clinical benefits are proven in large randomised controlled trials.
Results from these trials have found that using STAN® results in fewer blood samples (Fetal Blood Sampling (FBS) has been virtually eliminated in hospitals where STAN® is fully implemented), less surgical assistance and reduced incidence of metabolic acidosis at birth than conventional CTG.
STAN® FECG ST-Analysis Improves Decision Making
STAN® provides continuous analysis of the Fetal ECG and provides the user with
instantaneous information about the response of the foetus to intrapartum hypoxia.
This information can be compared to frequent Fetal Blood Sampling.
STAN® automatically displays alarms on the CTG trace to warn the user of any
abnormal Fetal ECG events, which needs to be acknowledge by the user.
- Improves CTG Interpretation
STAN® improves inter-observer agreement by focusing the observer to the CTG when
Fetal ECG changes occur.
STAN® provides reassurance when intervention is not required.
STAN® FECG ST-Analysis is Safer for Baby and Mother
Using STAN® has proven to significantly reduce the rate of metabolic acidosis at birth
and a likely reduction in the incidence of neonatal encephalopathy
Using STAN® has proven to give the mother a better chance of a normal spontaneous
delivery
- More Timely Interventions
Using STAN® enables a more timely intervention resulting in less Caesarean Sections
and less Complicated Instrumental Deliveries
Fetal Blood Sampling (FBS) is eliminated in hospitals where STAN® is implemented
STAN® Evidence Based Medicine
ST-Analysis is the analysis of changes occurring in the ST-segment of the Fetal ECG during labour.
STAN® is a fetal monitor that detects these changes in the Fetal ECG in addition to recording the CTG. The combined analysis of the CTG and Fetal ECG helps detect a fetus which is exposed to Hypoxia and needs remedial action or delivery.
This has been proven to reduce
Operative Interventions and Improve Outcome
